Claim Check: "A Doctor Offers It, Therefore It Is Approved"

The claim

"My doctor offers it, so it must be approved" sounds reasonable. This page checks it against what US regulators say. It is information only. It is not legal or medical advice, and it does not tell anyone to start, stop or change a medicine. Other countries have different rules, and we only report what we read from FDA and journal sources.

Evidence labels used: approved medicine, marketing claim, evidence of harm, insufficient evidence, Proper evidence not found.

What the claim says

The claim treats a licensed professional offering a product as the same as a regulator approving it. Licensing and approval are different things. A licence allows a professional to practice. Approval is a regulator's review of a specific drug for a specific use.

What FDA says

FDA states that compounded drugs are not FDA approved, and that the agency does not review them for safety, effectiveness or quality before they are marketed. [1] FDA also says compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug. [2]

FDA acknowledges that a compounded drug might be appropriate when a patient's need cannot be met by an approved drug, and that product is still not approved. [2] In the US, pharmacies compounding under section 503A may only use bulk substances that meet a USP or NF monograph, are components of an approved drug, or are on FDA's 503A bulks list. [3] Availability through a pharmacy therefore says nothing about approval, and it does not by itself say a given peptide qualifies.

FDA also keeps a list of bulk substances that may present significant safety risks for compounding. It includes several promoted peptides, with reasons such as immunogenicity risk and lack of human safety data. [4] The page we read was current as of 04/22/2026. It separates substances in category 2 from those previously in category 2 whose nominations were withdrawn, so a compound's position there needs reading, not assuming.

Red flags FDA lists for telehealth

FDA describes warning signs for consumers, including a company that claims a compounded drug is the same as an FDA-approved drug, does not require screening and a prescription by a licensed doctor, or has labels with spelling errors or a pharmacy name that may be fraudulent. [2] In some cases FDA found that pharmacies named on labels did not exist. [2]

Bottom line

"A doctor offers it" is not evidence of approval. Check what the product is called by the regulator (approved, compounded, investigational), what the evidence is for your use, and ask the prescriber. This page cannot judge any particular clinic.

Related guides

See how to evaluate peptide claims and clinic marketing, approved, off-label and investigational use, compounded medicines, and talking with a health professional.